Pandemic Patients header logo.

Dec. 9, 2021 – FDA Expands Vaccine Booster Eligibility to 16 Years and Older

On December 9, 2021, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine (marketed as Comirnaty). The amended EUA now allows individuals 16 and 17 years of age to receive a booster dose of the Pfizer-BioNTech vaccine at least six months after completion of the primary vaccination series with the same vaccine. Allowing these individuals to receive a booster dose heading into the holiday season is a welcome development as researchers race to study the new Omicron variant, which has demonstrated antibody resistance. Are you planning on meeting with friends and family during the holidays? Pandemic Patients recommends consulting with your health care provider to discuss getting vaccinated as soon as possible. 

Unsure if you’re eligible to receive a COVID-19 vaccine or booster? Check out our COVID-19 Vaccine Eligibility Guide.

FDA Authorizes First Vaccine Booster for Children 5-11

On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine (marketed as Comirnaty) to authorize the use of a single booster dose for children between the ages of five and eleven. The FDA authorized the administration of this booster at least five months after the completion of the primary vaccination series with the same vaccine.

Continue Reading...

R.T. Asked: When Can I Get the COVID-19 Booster After Receiving Monoclonal Antibodies?

“When should immunocompromised patients get their second COVID-19 vaccine booster after receiving monoclonal antibodies? We are getting conflicting information from doctors, the news, medical literature, and hospitals on whether it is safe to receive a COVID-19 vaccine or vaccine booster after receiving monoclonal antibodies and whether doing this will reduce the efficacy of the vaccine. We are in a quandary, not knowing what to do.”

Continue Reading...

Pandemic Patients is a 501(c)(3) non-profit organization that works to relieve the harm caused by COVID-19 and post-COVID conditions. EIN 86-3930257.

Please consider making a charitable donation to help us advance our important work.

Prior to using this website, please review our Terms of Use and Privacy Policy.